LL-37 fragment (17-32)
- Cat.Number : AS-65452-1
- Manufacturer Ref. :
-
Availability :
In production
Alternative choices
This peptide is an active segment of LL-37, a peptide derived from the C-terminal domain of human cathelicidin antimicrobial peptide. It has been reported that the LL17-32 peptide exhibits reversal effect on ABCG2-mediated multidrug resistance in cancer cell lines.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Downloads
You may also be interested in the following product(s)
Citations
Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region
J Am Chem Soc . 2006 May 03 ; 128(17) 5776 | DOI : 10.1021/ja0584875
- X. Li
- et al
References
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Biochim Biophys Acta . 2006 Sep 01 ; 1758(9) 1408 | DOI : https://doi.org/10.1016/j.bbamem.2006.03.030
- UHN. Dürr
- et al
Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells
Peptides . 2013 Feb 01 ; 40 13 | DOI : https://doi.org/10.1016/j.peptides.2012.12.019
- KK. To
- et al